Figure 14From: Comparison of the efficacy of lamivudine and telbivudine in the treatment of chronic hepatitis B: a systematic reviewEnd of one-years and two-years in biochemical response, virological response, HBeAg seroconversion, HBeAg loss, therapeutic response.Back to article page